5-Aza-2′-deoxycytidine and TSA reactivate angiogenesis by inhibiting antiangiogenic agents by direct methylation to the promoter of TSP1, JUNB, and IGFBP3 genes, which are suppressed in tumor-conditioned ECs. This evidence concerns the gene THBS1 and neoplasm.